- CannaPharmaRx ( OTCPK:CPMD ) on Wednesday signed a genetics transfer agreement with Canadian cannabis company High Profile Cannabis.
- As per the deal, High Profile will deliver live cannabis plants and seeds to CPMD, which will use them to produce finished cannabis products.
- CPMD has applied to Canada's drug regulator to be a licensed producer.
- The companies will negotiate a supply agreement which will continue for at least 12 months, under which High Profile will purchase product from CPMD on mutual terms.
For further details see:
CannaPharmaRx enters into a genetics transfer agreement with High Profile Cannabis